Arrowhead Pharmaceuticals has entered a worldwide licensing and partnership agreement with Sarepta Therapeutics to develop ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its 2024 fiscal year ended September 30, 2024. The Company is hosting a conference ...

PASADENA, Calif., November 18, 2024--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA ...

Dynavax Technologies Corporation , a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will present at the 7th Annual ...

Waystar Holding Corp. , a provider of leading healthcare payment software, today announced that Chief Executive Officer Matt Hawkins will speak at two upcoming investor ...

Prime has ambitious production plans for the Raiders-Chiefs matchup. The post Inside Amazon Prime Video’s Plan to Own Black Friday—With Football appeared first on Front Office Sports.

Welcome to Tumacacori National Historical Park, a hidden gem nestled in the heart of southern Arizona. Picture this: You’re ...

The full article can be seen at https://newsroom.nmsu.edu/news/nmsu-learning-games-lab-celebrates-20-years-of-teaching-through-interactive-programs/s/22d06c46-127e-459a-8a40-34bbcd429591 ...

Sarepta Therapeutics is paying Arrowhead Pharmaceuticals $500 million in cash, plus a $325 million equity investment, for ...

Arrowhead Pharmaceuticals, Inc. ( (ARWR) ) has released its Q4 earnings. Here is a breakdown of the information Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals is a biotechnology company focused on developing RNA interference (RNAi) therapeutics. Their proprietary platform, Targeted RNAi Molecule (TRiM™), allows them to target and ...

BridgeBio’s Attruby wins approval for transthyretin amyloid cardiomyopathy while the FDA accepts Alnylam’s application for ...